Clinical Trials

Liraglutide has been evaluated across numerous clinical trials ranging from early-stage through Phase IV development. Sponsored by academic institutions, biopharmaceutical companies, and major pharmaceutical manufacturers such as Novo Nordisk A/S, Sanofi, and Eli Lilly and Company, these studies encompass completed trials, active recruiting protocols, and post-marketing surveillance. Primary research targets metabolic disorders, including type 1 and type 2 diabetes mellitus and obesity, alongside exploratory indications such as knee osteoarthritis.

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06742710 RECRUITING
PCOS; Obesity; Infertility
Peking University Third Hospital
 2025-05-22 PHASE4
NCT06976619 RECRUITING
Type 1 Diabetes; Type 2 Diabetes
Mayo Clinic
 2025-10-03 PHASE2
NCT05681299 RECRUITING
Healthy; Growth Hormone Deficiency
Columbia University
 2023-05-01 PHASE4
NCT07244003 RECRUITING
T2DM (Type 2 Diabetes Mellitus)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
 2025-03-29 PHASE4
NCT07301437 NOT_YET_RECRUITING
Overweight and Obese Adults
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
 2026-05-01 PHASE4
NCT06171152 SUSPENDED
Multiple Sclerosis; Long COVID; Long Covid19; Obese; Obesity; Obesity, Morbid; Acute Leukemia in Remission
University of Chicago
 2024-01-26 EARLY_PHASE1
NCT02944500 ACTIVE_NOT_RECRUITING
Obesity
Beth Israel Deaconess Medical Center
 2016-11 PHASE4
NCT03883412 RECRUITING
Type2 Diabetes
University of Virginia
 2019-02-28 PHASE4
NCT04575844 RECRUITING
Metabolic Syndrome
University of Virginia
 2020-11-01 PHASE4
NCT06836284 RECRUITING
Childhood Obesity; Treatment Adherence
Karolinska Institutet
 2026-02-13
NCT07590219 ACTIVE_NOT_RECRUITING
Severe Obesity; Cardiovascular Function; Liraglutide; Childhood Obesity; Echocardiography; Speckle Tracking
University of Sao Paulo General Hospital
 2024-03-30 PHASE4
NCT06361238 RECRUITING
Delirium, Postoperative
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
 2024-11-19 PHASE3
NCT06865365 NOT_YET_RECRUITING
Obesity, Adolescent
Medical University of Vienna
 2025-05-01 PHASE4
NCT03856632 ACTIVE_NOT_RECRUITING
Atrial Fibrillation
University of Miami
 2019-03-18 PHASE4
NCT07225816 RECRUITING
Obesity
Novo Nordisk A/S
 2025-11-07 PHASE1
NCT07029009 RECRUITING
Maturity Onset Diabetes of the Young
Mansa
 2025-05-08 PHASE2
NCT05952882 UNKNOWN
Polycystic Ovary Syndrome; Obesity; Infertility, Female
Mỹ Đức Hospital
 2023-11-01 PHASE3
NCT05313529 COMPLETED
Type 2 Diabetes Mellitus; Mild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
 2022-10-08
NCT06925334 ENROLLING_BY_INVITATION
Type 2 Diabetic Patients
Beijing Tsinghua Chang Gung Hospital
 2024-05-20 PHASE4
NCT05268237 RECRUITING
Diabete Type 2
Biolingus
 2023-04-25 PHASE1; PHASE2
NCT05965908 COMPLETED
Polycystic Ovary
Beni-Suef University
 2024-08-01 PHASE3
NCT04683237 WITHDRAWN
Atypical Endometrial Hyperplasia; Obese; Fertility Issues
Xiaojun Chen
 2021-03-20 PHASE2; PHASE3
NCT06559722 UNKNOWN
Type 2 Diabetes
Tonghua Dongbao Pharmaceutical Co.,Ltd
 2024-08 PHASE3
NCT06439056 COMPLETED
Type 2 Diabetes
Nanexa AB
 2024-05-27 PHASE1
NCT07374445 COMPLETED
Obesity; Weight Loss; Bariatric Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
 2023-09-01 PHASE4
NCT03011021 UNKNOWN
Type1 Diabetes Mellitus; Autoimmune Diabetes
Second Xiangya Hospital of Central South University
 2017-01 PHASE1; PHASE2
NCT06438146 UNKNOWN
Obesity; HIV Infections
Brigham and Women's Hospital
 2024-05-02 PHASE4
NCT05779644 UNKNOWN
Metformin; Obesity, Abdominal; Diabetes Mellitus, Type 2; Abdominal Fat; Non-Alcoholic Fatty Liver Disease; Metabolism Disorder, Glucose; Metabolism Disorder, Lipid
RenJi Hospital
 2023-02-23
NCT03087032 RECRUITING
Type 2 Diabetes Patients; Overweight and Obesity; Hyperglycaemia (Diabetic)
The First Affiliated Hospital of Xiamen University
 2019-01-10 PHASE4
NCT05705388 UNKNOWN
Obesity
Emirates Health Services (EHS)
 2023-01-16
NCT06400615 COMPLETED
OSA
Apnimed
 2024-05-20 PHASE2
NCT06818292 COMPLETED
Healthy
Nils Opel
 2024-10-21
NCT05579249 COMPLETED
Obesity
Novo Nordisk A/S
 2023-01-19 PHASE4
NCT06501326 UNKNOWN
Non-alcoholic Fatty Liver Disease; Obesity
Affiliated Hospital of Nantong University
 2023-11-01 PHASE4
NCT06500130 COMPLETED
Gastroparesis; Functional Dyspepsia; Chronic Nausea and Vomiting Syndrome; Healthy
Alimetry
 2024-05-30
NCT04324229 ACTIVE_NOT_RECRUITING
Gestational Diabetes
Turku University Hospital
 2020-02-07
NCT03260881 COMPLETED
Type2 Diabetes; Coronary Artery Disease
University of Miami
 2018-09-01 PHASE4
NCT03182426 COMPLETED
Diabetes Mellitus, Type 1
University of Alberta
 2017-08-15 PHASE1; PHASE2
NCT06449703 UNKNOWN
Healthy
Tonghua Dongbao Pharmaceutical Co.,Ltd
 2024-05-06 PHASE1
NCT04883346 COMPLETED
Obesity; Status Post Sleeve Gastrectomy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
 2021-06-21 PHASE2
NCT06283641 Enrolling by invitation
Obesity
Novo Nordisk A/S
 2024-02-23 --
NCT05390307 COMPLETED
Type 1 Diabetes
Dasman Diabetes Institute
 2023-04-01
NCT03948347 UNKNOWN
Ischemic Stroke; Transient Ischemic Attack; Type 2 Diabetes Mellitus
First Affiliated Hospital of Jinan University
 2019-06-25
NCT04763564 TERMINATED
Pouchitis; Irritable Pouch Syndrome
University of North Carolina, Chapel Hill
 2022-03-22 PHASE2
NCT02879409 ACTIVE_NOT_RECRUITING
Diabetes Mellitus Type 2
Weill Cornell Medical College in Qatar
 2016-11
NCT04535960 UNKNOWN
Type 2 Diabetes Mellitus
University Health Network, Toronto
 2019-01-24 PHASE2
NCT04199728 COMPLETED
Opiate Substitution Treatment; Opioid-Related Disorders
Milton S. Hershey Medical Center
 2021-10-18 PHASE1; PHASE2
NCT05767255 UNKNOWN
Diabetes Mellitus, Type 2 Treated With Insulin
Hospital Universitario San Ignacio
 2022-12-01 PHASE3
NCT04775082 ACTIVE_NOT_RECRUITING
Obesity
Novo Nordisk A/S
 2021-03-04 PHASE3
NCT05268237 Recruiting
Diabete Type 2
Biolingus|Chinese University of Hong Kong
 2023-04-25 Phase 1|Phase 2
NCT06201819 COMPLETED
Weight Loss; Bariatric Surgery Candidate; Obesity, Morbid
Hospital Civil Juan I. Menchaca
 2022-12-18 PHASE4
NCT05467514 COMPLETED
Diabetes Mellitus, Type 1
David Sanchez Garcia
 2022-07-01 PHASE3
NCT05444569 COMPLETED
Healthy
Eli Lilly and Company
 2022-08-08 PHASE1
NCT05268627 UNKNOWN
Obesity
Mansoura University
 2022-01-27
NCT04529278 UNKNOWN
Diabetes Mellitus, Type 2; Hemodialysis; Obese
Fondation Hôpital Saint-Joseph
 2021-01-18 PHASE2
NCT04881110 COMPLETED
Type 2 Diabetes; Peripheral Arterial Disease
University of Campania Luigi Vanvitelli
 2021-02-01 PHASE4
NCT04605861 COMPLETED
Obese; Overweight
Shanghai Zhongshan Hospital
 2020-08-18 PHASE3
NCT02344186 UNKNOWN
Type 2 Diabetes
Temple University
 2014-05 PHASE4
NCT04311411 COMPLETED
Obesity; Overweight
Eli Lilly and Company
 2020-08-24 PHASE1
NCT04137328 UNKNOWN
Diabetic Neuropathic Pain
Fudan University
 2019-11-30
NCT05111912 COMPLETED
Obesity
Sciwind Biosciences APAC CO Pty. Ltd.
 2021-11-30 PHASE2
NCT04657939 COMPLETED
Diabetes Mellitus, Type 2
University of Leeds
 2020-12-01 PHASE4
NCT03158805 COMPLETED
Bipolar Disorder; Obesity
Lindner Center of HOPE
 2017-04-26 PHASE2
NCT04575194 UNKNOWN
Obesity; Blood Pressure
National and Kapodistrian University of Athens
 2020-09-08 PHASE4
NCT03671733 UNKNOWN
Obesity
Xiangya Hospital of Central South University
 2018-09-01 PHASE3
NCT05285397 UNKNOWN
Morbid Obesity
General Committee of Teaching Hospitals and Institutes, Egypt
 2022-03-10
NCT04903509 COMPLETED
Healthy
Boehringer Ingelheim
 2021-06-08 PHASE1
NCT04531176 TERMINATED
Type 2 Diabetes; Obesity
The Cleveland Clinic
 2020-09-01 PHASE4
NCT02953665 COMPLETED
Parkinson Disease
Cedars-Sinai Medical Center
 2017-04-03 PHASE2
NCT02516657 COMPLETED
Type 1 Diabetes
University at Buffalo
 2012-05 PHASE3
NCT05419856 Completed
Knee Osteoarthritis
4Moving Biotech|4P-Pharma
 2022-08-09 Phase 1
NCT04057261 WITHDRAWN
Type 2 Diabetes; Cardiovascular Diseases
RWTH Aachen University
 2020-11 PHASE3
NCT04781998 COMPLETED
Mental Disorder; Metabolic Disturbance; Feasibility; Overweight and Obesity; Liraglutide
Anders Fink-Jensen, MD, DMSci
 2021-07-01 PHASE4
NCT05467514 Completed
Diabetes Mellitus Type 1
David Sanchez Garcia|Instituto Mexicano del Seguro Social
 2022-07-01 Phase 3
NCT04487743 UNKNOWN
Obesity
Xiangya Hospital of Central South University
 2020-05-09 PHASE3
NCT04525300 UNKNOWN
Obesity
Xiangya Hospital of Central South University
 2020-05-24 PHASE3
NCT03374956 COMPLETED
Obesity
Mayo Clinic
 2017-12-11 PHASE3
NCT03712098 COMPLETED
Smoking Cessation; Weight, Body
Rebecca Ashare
 2018-11-29 PHASE2
NCT02960659 COMPLETED
Type 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 2017-05-09 PHASE1; PHASE2
NCT03795701 COMPLETED
Obesity
Texas Tech University
 2019-01-08
NCT04186494 COMPLETED
Sleep Apnea, Obstructive
St Vincent's University Hospital, Ireland
 2019-12-02
NCT04643301 WITHDRAWN
Obesity; Obesity, Morbid
Zuyderland Medisch Centrum
 2020-12-21
NCT04146155 UNKNOWN
Type 2 Diabetes; Peripheral Vascular Disorder Due to Diabetes Mellitus
Second Affiliated Hospital, Zhejiang University, School of Medicine
 2020-05-01 PHASE4
NCT03986008 UNKNOWN
Obesity
Xiangya Hospital of Central South University
 2019-12-01 PHASE3
NCT04373967 UNKNOWN
Type 2 Diabetes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 2020-04-29 PHASE3
NCT05360537 COMPLETED
Diabetes Mellitus, Type 2
University of Palermo
 2021-04-01 PHASE4
NCT03632759 COMPLETED
Type 1 Diabetes Mellitus
Carla Greenbaum, MD
 2018-08-15 EARLY_PHASE1
NCT05041673 UNKNOWN
Fatty Liver, Nonalcoholic; Diabetes Mellitus, Type 2
Alexandria University
 2021-02-23
NCT02920190 WITHDRAWN
Monoclonal Gammopathies; Overweight; Obesity
University of Miami
 2020-09-01 PHASE4
NCT03523273 COMPLETED
Obesity
Michael Camilleri, MD
 2017-11-29 PHASE2
NCT05225974 COMPLETED
Therapeutic Equivalency
The Affiliated Hospital of Qingdao University
 2021-07-16 PHASE1
NCT03101930 COMPLETED
Obesity; PreDiabetes
Vanderbilt University Medical Center
 2017-05-01 PHASE4
NCT02908087 COMPLETED
Type 1 Diabetes
University of Oulu
 2016-03 PHASE2
NCT01794143 COMPLETED
Type 2 Diabetes; Comparative Effectiveness of Glycemia-lowering Medications
GRADE Study Group
 2013-05 PHASE3
NCT02403284 COMPLETED
Insulin Resistance
Phoenix VA Health Care System
 2013-03 PHASE4
NCT05360147 COMPLETED
Type 2 Diabetes Mellitus
Third Military Medical University
 2021-01-20 PHASE3
NCT03555994 COMPLETED
Type 2 Diabetes Mellitus
MedImmune LLC
 2018-05-31 PHASE2
NCT04008290 UNKNOWN
Obesity
Universitaire Ziekenhuizen KU Leuven
 2020-04-01 PHASE4
NCT04829903 COMPLETED
Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
Corporacion Parc Tauli
 2020-01-02
NCT04074161 COMPLETED
Overweight; Obesity
Novo Nordisk A/S
 2019-09-11 PHASE3
NCT03955575 COMPLETED
Bile Acid Malabsorption
Filip Krag Knop
 2019-03-07 PHASE4
NCT03048578 COMPLETED
Obesity
NYU Langone Health
 2017-05-22 PHASE4
NCT03036800 COMPLETED
Obesity; Weight Loss; Diabetes Mellitus
University of Leicester
 2017-11-28 PHASE4
NCT03480022 COMPLETED
Pre Diabetes; Polycystic Ovary Syndrome; Obesity Android
Woman's
 2018-09-26 PHASE3
NCT04839237 WITHDRAWN
Obesity
Xiangya Hospital of Central South University
 2017-12-01 PHASE2
NCT03011008 UNKNOWN
Type 1 Diabetes Mellitus; Autoimmune Diabetes
Second Xiangya Hospital of Central South University
 2017-01 PHASE4
NCT02527200 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2015-11-09 PHASE3
NCT03038620 COMPLETED
Obesity, Visceral; Cardiovascular Diseases; Fat Disorder
University of Texas Southwestern Medical Center
 2017-01 PHASE4
NCT02617654 COMPLETED
Type 1 Diabetes
Per-Ola Carlsson
 2015-11 PHASE2
NCT01919489 COMPLETED
Type 2 Diabetes
Emory University
 2014-03 PHASE4
NCT03371862 WITHDRAWN
Short Bowel Syndrome
Imperial College London
 2017-10-20 PHASE2
NCT05294536 COMPLETED
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd.
 2020-06-22 PHASE1
NCT02198209 WITHDRAWN
Type 2 Diabetes
Cedars-Sinai Medical Center
 2019-12 PHASE4
NCT03500484 TERMINATED
Obesity, Childhood; Neural Development
Yale University
 2018-06-06 EARLY_PHASE1
NCT03466021 COMPLETED
Pulmonary Disease, Chronic Obstructive
Claus Bogh Juhl
 2018-01-01 PHASE4
NCT03426085 UNKNOWN
Autonomic Nervous System Diseases; Sweat Gland Diseases; Diabetic Neuropathy With Neurologic Complication
Eastern Virginia Medical School
 2016-05 PHASE2
NCT03347890 COMPLETED
Obesity
Zoltan Pataky
 2018-03-05 PHASE4
NCT03856047 COMPLETED
Overweight; Obesity
Novo Nordisk A/S
 2019-03-01 PHASE2
NCT03642600 COMPLETED
PCOS; Obesity; Metabolic Syndrome
Universitaire Ziekenhuizen KU Leuven
 2019-02-28 PHASE4
NCT04046822 UNKNOWN
Obesity; Weight Loss; Microbiome
Federico II University
 2019-01-09 PHASE4
NCT03757130 COMPLETED
Obesity
Amgen
 2018-11-26 PHASE1
NCT03672812 COMPLETED
Brain Death
Hospital de Clinicas de Porto Alegre
 2018-09-01 PHASE3
NCT03421119 UNKNOWN
Diabetes Mellitus, Type 2
Cinnagen
 2019-06-20 PHASE3
NCT02655770 COMPLETED
Diabetes Mellitus Type 2; Diastolic Dysfunction; Cardiac MRI; Myocardial Perfusion
Rigshospitalet, Denmark
 2016-02 PHASE4
NCT01843075 UNKNOWN
Alzheimer's Disease
Imperial College London
 2014-01 PHASE2
NCT03341429 COMPLETED
Obesity
University College, London
 2018-08-22 PHASE4
NCT04190160 COMPLETED
Type2 Diabetes
Stefano Rizza
 2018-11-19
NCT02889510 COMPLETED
Type 2 Diabetes
Lecube, Albert, M.D.
 2016-10-04 PHASE3
NCT04122716 UNKNOWN
Obesity
Signe Torekov
 2016-09 PHASE4
NCT02721888 TERMINATED
Type 2 Diabetes
Centre Hospitalier Universitaire Dijon
 2012-07-10 PHASE4
NCT03279731 TERMINATED
Binge-Eating Disorder
Kelly Allison
 2017-09-29 PHASE3
NCT02650206 COMPLETED
Diabetes Mellitus, Type 2; Diabetes Mellitus, Type II; Diabetes Mellitus, Adult-Onset; Inflammation
Stanford University
 2015-01 PHASE1
NCT01795248 COMPLETED
Gestational Diabetes Mellitus
Tina Vilsboll
 2012-07 PHASE4
NCT03449654 COMPLETED
Diabetes Mellitus, Type 2
Steno Diabetes Center Copenhagen
 2017-10-26 PHASE4
NCT02730377 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2016-03-28 PHASE4
NCT03172494 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-05-26 PHASE3
NCT05029076 COMPLETED
Type 2 Diabetes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 2019-05-21 PHASE1
NCT03520062 COMPLETED
Obesity
Nicolai Jacob Wewer Albrechtsen
 2017-08-15
NCT01234649 COMPLETED
Gestational Diabetes Mellitus; Type 2 Diabetes Mellitus; Metabolic Syndrome; Impaired Glucose Tolerance; Disorder of Glucose Regulation
Woman's
 2011-08-11 PHASE3
NCT03486392 COMPLETED
Obesity
Janssen Research & Development, LLC
 2018-03-26 PHASE2
NCT03175120 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-05-26 PHASE3
NCT02488057 COMPLETED
Pre-Diabetes
Ohio State University
 2016-05 PHASE4
NCT02765399 COMPLETED
Type 2 Diabetes
Helsinki University Central Hospital
 2015-02-01 PHASE4
NCT02928679 COMPLETED
Osteoarthritis; Obesity
Henrik Gudbergsen
 2016-11 PHASE4
NCT02918279 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2016-09-29 PHASE3
NCT03707171 COMPLETED
Type 2 Diabetes Mellitus
Third Military Medical University
 2018-10-01 PHASE3
NCT02910570 COMPLETED
Osteoarthritis, Knee
Parker Research Institute
 2016-11 PHASE4
NCT01779362 COMPLETED
Prediabetes; Type 2 Diabetes
RISE Study Group
 2013-04 PHASE3
NCT02931383 COMPLETED
Osteoarthritis; Obesity
Henrik Gudbergsen
 2016-11 PHASE4
NCT02928614 COMPLETED
Osteoarthritis; Obesity
Henrik Gudbergsen
 2016-11 PHASE4
NCT02905864 COMPLETED
Osteoarthritis; Obesity
Henrik Gudbergsen
 2016-11 PHASE4
NCT01722240 COMPLETED
Type 1 Diabetes
University at Buffalo
 2012-11-01 PHASE3
NCT04325581 COMPLETED
Weight Loss
Post Graduate Institute of Medical Education and Research, Chandigarh
 2016-08-01 PHASE3
NCT02535299 UNKNOWN
GLP-1；Metformin；Telomere-telomerase System；Par-4
Third Military Medical University
 2016-06 PHASE4
NCT02911818 COMPLETED
Obesity
University of Pennsylvania
 2016-09 PHASE4
NCT02501161 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2016-01-31 PHASE3
NCT02963922 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2017-02-06 PHASE3
NCT02443155 COMPLETED
Diabetes; Diabetes Mellitus, Type 1
Novo Nordisk A/S
 2015-11-10 PHASE2
NCT01879917 COMPLETED
Diabetes Mellitus, Type 1
Hvidovre University Hospital
 2014-02 PHASE2; PHASE3
NCT02231658 TERMINATED
Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH
 2015-07-16 PHASE1
NCT03191396 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-06-27 PHASE3
NCT02743598 TERMINATED
HIV Infection; Diabetes Mellitus Type 2; Obesity; Overweight; Metabolic Syndrome
Temple University
 2016-09 PHASE4
NCT02787551 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2016-07-06 PHASE3
NCT02963935 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2017-02-06 PHASE3
NCT02964247 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-03-03 PHASE3
NCT03235050 COMPLETED
Diabetes Mellitus, Type 2
AstraZeneca
 2017-08-02 PHASE2
NCT03115099 COMPLETED
Diabetes Mellitus, Type 2
Eli Lilly and Company
 2017-05-31 PHASE1
NCT02324842 COMPLETED
Type 2 Diabetes Mellitus
The University of Texas Health Science Center at San Antonio
 2014-11
NCT02660047 COMPLETED
Diabetes Mellitus Type 2; Metabolic Syndrome; Cardiovascular Disease; Diastolic Dysfunction; Fatty Liver
Leiden University Medical Center
 2015-08 PHASE4
NCT02060383 COMPLETED
Cushing's Disease; Acromegaly
Novartis Pharmaceuticals
 2014-05-23 PHASE4
NCT02650596 UNKNOWN
Heart Failure
Shi Yang
 2016-01
NCT02930265 UNKNOWN
Ischemic Cardiomyopathy
Chinese PLA General Hospital
 2016-09
NCT03041792 COMPLETED
Obesity
Pfizer
 2017-02-20 PHASE1
NCT03018028 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-01-10 PHASE3
NCT03292185 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-09-29 PHASE1
NCT02616003 COMPLETED
Morbid Obesity; Bariatric Surgery Candidate
Sana Klinikum Offenbach
 2014-04 PHASE4
NCT02973321 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2016-12-02 PHASE2
NCT02607306 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2015-11-18 PHASE3
NCT01753362 COMPLETED
Type 1 Diabetes
University at Buffalo
 2012-12 PHASE3
NCT01966978 COMPLETED
Diabetes Mellitus, Type 2; Diabetes
University of Texas Southwestern Medical Center
 2014-11 PHASE4
NCT02654665 UNKNOWN
Non-alcoholic Fatty Liver Disease (NAFLD); Weight Loss; Non-alcoholic Steatohepatitis (NASH)
Changi General Hospital
 2014-03 PHASE3
NCT02911948 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2016-09-21 PHASE3
NCT01541215 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-11-13 PHASE3
NCT01722227 WITHDRAWN
Type 1 Diabetes
University at Buffalo
 2012-11 PHASE3
NCT02473809 COMPLETED
Diabetes Complications; Osteoporosis
University of Aarhus
 2015-08 PHASE4
NCT02638805 COMPLETED
Diabetes Mellitus, Type 2
Intarcia Therapeutics
 2015-12 PHASE3
NCT02773368 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2016-05-23 PHASE3
NCT01232946 COMPLETED
Type 2 Diabetes
Indiana University
 2012-01
NCT02870231 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2016-08-18 PHASE1
NCT02043054 COMPLETED
Type 2 Diabetes Mellitus; Cardiovascular Disease
University of Leicester
 2013-12-16 PHASE3
NCT02863419 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2016-08-10 PHASE3
NCT02686177 COMPLETED
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris
 2016-05-18 PHASE4
NCT03010683 COMPLETED
Type 2 Diabetes Mellitus; Coronary Artery Disease
University of Athens
 2015-11
NCT02505334 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2015-07-21 PHASE3
NCT02492763 TERMINATED
Type II Diabetes Mellitus
Merck Sharp & Dohme LLC
 2015-07-27 PHASE2
NCT02602600 COMPLETED
Microvascular Angina
Eva Prescott
 2015-11-19 PHASE4
NCT02696148 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2016-03-14 PHASE1
NCT02527993 COMPLETED
Hypoglycemia; Obesity; Surgery
Zealand University Hospital
 2015-10 PHASE4
NCT02147925 COMPLETED
Non-alcoholic Fatty Liver Disease
Sun Yat-sen University
 2014-08 PHASE4
NCT02453711 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2015-10-01 PHASE2
NCT02718950 UNKNOWN
Obesity; Type 2 Diabetes Mellitus
University of Campinas, Brazil
 2016-06 PHASE3
NCT02014740 COMPLETED
Type 2 Diabetes; Overweight; Obesity
University of Miami
 2014-03 PHASE4
NCT02055014 UNKNOWN
Type 2 Diabetes; Obesity; Diabesity
Sandwell & West Birmingham Hospitals NHS Trust
 2013-07 PHASE4
NCT02717858 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2016-03-16 PHASE1
NCT02138045 COMPLETED
Diabetes Mellitus, Type 1; Type 1 Diabetes Mellitus
Aalborg University Hospital
 2014-05
NCT02140983 COMPLETED
Insulin Resistance; Dementia
Stanford University
 2013-08 PHASE1
NCT03534310 COMPLETED
Obesity
Catholic University of the Sacred Heart
 2015-11-02
NCT02036372 COMPLETED
Diabetes Mellitus Type II
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
 2014-01
NCT02647944 COMPLETED
Obesity
Mayo Clinic
 2015-12-18 PHASE2
NCT02777073 COMPLETED
Type 1 Diabetes
University at Buffalo
 2016-03-01
NCT02783196 UNKNOWN
Type 2 Diabetes
Tel Aviv University
 2016-07
NCT03034941 COMPLETED
Obesity; PCOS
University Medical Centre Ljubljana
 2014-04 PHASE4
NCT02299388 COMPLETED
Diabetes Mellitus, Non-Insulin-Dependent; Hypertensive Disease
Tulane University School of Medicine
 2014-10 PHASE4
NCT02461589 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2015-09-21 PHASE2
NCT02420262 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2015-07-26 PHASE3
NCT02577848 UNKNOWN
Myocardial Infarction
Chinese PLA General Hospital
 2015-10
NCT02472717 WITHDRAWN
Psoriatic Arthritis; Psoriasis; Impaired Glucose Tolerance; Type 2 Diabetes
University Health Network, Toronto
 2015-05 PHASE2
NCT02351232 COMPLETED
Type 1 Diabetes
Hvidovre University Hospital
 2015-02 PHASE2; PHASE3
NCT02417103 TERMINATED
Obesity
Universitätsklinikum Hamburg-Eppendorf
 2011-12 PHASE3
NCT02503943 UNKNOWN
Type 2 Diabetes; Overweight; Obesity; Masked Hypertension
Third Affiliated Hospital of Third Military Medical University
 2015-05 PHASE4
NCT02832999 COMPLETED
Type 2 Diabetes Mellitus
Yaounde Central Hospital
 2016-01 PHASE4
NCT02674893 TERMINATED
Type 2 Diabetes; Overweight
Centre Hospitalier Universitaire Dijon
 2014-02-04 PHASE4
NCT01425580 COMPLETED
Congestive Heart Failure; Type 2 Diabetes Mellitus
Thomas Nystrom
 2012-01 PHASE2
NCT02235961 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2014-09-04 PHASE1
NCT02490176 UNKNOWN
Heart Failure
Chinese PLA General Hospital
 2015-07
NCT02507128 UNKNOWN
Acute ST-segment Elevation Myocardial Infarction
Chen Wei Ren, MD
 2015-07
NCT01505673 COMPLETED
Type 2 Diabetes Mellitus; Obesity
Ildiko Lingvay
 2012-01 PHASE4
NCT03353948 COMPLETED
Polycystic Ovary Syndrome; Obesity; Infertility, Female
University Medical Centre Ljubljana
 2014-09-01 PHASE4
NCT02545738 COMPLETED
Diabetic Kidney Disease
Steno Diabetes Center Copenhagen
 2015-04 PHASE4
NCT02408705 COMPLETED
Type 1 Diabetes Mellitus
Medical University of Graz
 2015-01 PHASE2
NCT02082496 COMPLETED
Obesity
University of Copenhagen
 2014-06 PHASE2
NCT02423824 COMPLETED
Bipolar Disorder; Major Depressive Disorder
University Health Network, Toronto
 2015-05 PHASE3
NCT02001363 UNKNOWN
Acute Myocardial Infarction
Chen Wei Ren, MD
 2013-11
NCT01845259 UNKNOWN
Impaired Glucose Tolerance Associated With Drugs
Psychiatric Centre Rigshospitalet
 2013-04 PHASE2
NCT01761318 COMPLETED
Diabetes Mellitus Type 2; Metabolic Syndrome; Cardiovascular Disease; Diastolic Dysfunction; Fatty Liver
Leiden University Medical Center
 2013-11 PHASE4
NCT02298192 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2014-11-21 PHASE3
NCT01179048 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2010-08-31 PHASE3
NCT02073929 COMPLETED
Polycystic Ovary Syndrome; Cardiovascular Disease
Jens Faber
 2014-03 PHASE4
NCT02518945 COMPLETED
Type 1 Diabetes Mellitus
University at Buffalo
 2015-08 PHASE3
NCT01740921 COMPLETED
Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust
 2011-01
NCT01832532 COMPLETED
Sleep Apnea; Sleep Disordered Breathing
Children's Hospital Medical Center, Cincinnati
 2013-04 PHASE1; PHASE2
NCT01847313 COMPLETED
Diabetic Kidney Disease
Karl Neff
 2013-04 PHASE3
NCT02584582 UNKNOWN
Type 1 Diabetes
Hvidovre University Hospital
 2015-07 PHASE2; PHASE3
NCT01628445 TERMINATED
Type 2 Diabetes
University of Manitoba
 2012-08 PHASE3
NCT01856790 COMPLETED
Type 1 Diabetes
Jennifer Sherr
 2013-02 EARLY_PHASE1
NCT02072096 TERMINATED
Diabetes Mellitus, Type 2
Eli Lilly and Company
 2014-02 PHASE4
NCT02909933 COMPLETED
Polycystic Ovary Syndrome; Obesity
University Medical Centre Ljubljana
 2015-07 PHASE4
NCT01800968 COMPLETED
Acute Heart Failure
Duke University
 2013-04 PHASE2
NCT02205528 COMPLETED
Diabetes; Diabetes Mellitus Type 2
Novo Nordisk A/S
 2014-08-18 PHASE2
NCT01472640 COMPLETED
Hyperglycemia; Chronic Heart Failure
Flyvbjerg, Allan, DMSc
 2011-11
NCT01744236 COMPLETED
Type 2 Diabetes
Amsterdam UMC, location VUmc
 2013-04 PHASE4
NCT02284230 WITHDRAWN
Kidney Failure, Chronic; Prediabetic State
Bo Feldt-Rasmussen
 2014-12 PHASE2
NCT03619330 COMPLETED
Hypogonadism; Obesity
University Medical Centre Ljubljana
 2014-12 PHASE4
NCT02501850 UNKNOWN
Diabetes Mellitus Type 2
Hospital Universitari Vall d'Hebron Research Institute
 2014-10 PHASE4
NCT01575301 COMPLETED
Diabetes
University of Dundee
 2011-03
NCT01907854 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-12-02 PHASE4
NCT01836523 COMPLETED
Diabetes; Diabetes Mellitus, Type 1
Novo Nordisk A/S
 2013-11 PHASE3
NCT02109315 WITHDRAWN
Type 1 Diabetes Mellitus
Anna Cruceta
 2014-05 PHASE1
NCT02098395 COMPLETED
Diabetes; Diabetes Mellitus, Type 1
Novo Nordisk A/S
 2014-05 PHASE3
NCT01787916 COMPLETED
Type 1 Diabetes
CHU de Quebec-Universite Laval
 2013-04 PHASE4
NCT02100475 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2014-04 PHASE3
NCT02483299 COMPLETED
PCOS; Obesity
University Medical Centre Ljubljana
 2014-01 PHASE4
NCT02089256 COMPLETED
Healthy
University of Tartu
 2014-06 PHASE4
NCT02315001 COMPLETED
Ischaemic Heart Disease; Coronary Heart Disease; Chronic Stable Angina
King's College London
 2014-01 PHASE2
NCT01612468 COMPLETED
Diabetes Mellitus, Type 1; Overweight
Steno Diabetes Center Copenhagen
 2012-06 PHASE4
NCT01782261 COMPLETED
Type 1 Diabetes
Medical University of Graz
 2012-02 PHASE2
NCT02016846 UNKNOWN
Glucocorticoid Induced Hyperglycemia
Rabin Medical Center
 2014-01 PHASE3
NCT01755416 COMPLETED
Type 1 Diabetes
Albert Einstein College of Medicine
 2013-01 PHASE2
NCT01363609 COMPLETED
Obesity; Type 2 Diabetes
Amsterdam UMC, location VUmc
 2011-10
NCT01870297 COMPLETED
Type 2 Diabetes Mellitus
Eli Lilly and Company
 2013-06 PHASE1
NCT01790308 UNKNOWN
Diabetes Mellitus, Type 2
Sun Yat-sen University
 2013-02 PHASE4
NCT01952145 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-09-20 PHASE3
NCT03068065 COMPLETED
Non-Alcoholic Fatty Liver Disease; Type2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
 2014-05 PHASE4
NCT01973231 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-10 PHASE4
NCT02008682 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-12 PHASE4
NCT01982630 COMPLETED
Diabetes Mellitus
Merck Sharp & Dohme LLC
 2013-11-07 PHASE1
NCT01595789 COMPLETED
Coronary Artery Disease; Diabetes Mellitus, Type 2
Haugaard, Steen Bendix, M.D., DMSc
 2012-05 PHASE4
NCT02057172 COMPLETED
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited
 2014-01 PHASE2
NCT02092896 COMPLETED
Diabetes; Diabetes Mellitus, Type 1
Hvidovre University Hospital
 2013-03 PHASE3
NCT01954147 UNKNOWN
Type 2 Diabetes
Diabetes Care Center of Nanjing Military Command
 2013-10 PHASE1; PHASE2
NCT01917656 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2014-01-09 PHASE4
NCT02207348 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2014-08 PHASE1
NCT02113332 COMPLETED
Type 2 Diabetes Mellitus
Vastra Gotaland Region
 2013-01 PHASE2
NCT01237119 COMPLETED
Nonalcoholic Steatohepatitis
University of Birmingham
 2010-08 PHASE2
NCT01399645 COMPLETED
Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; Type 2 Diabetes
Centre hospitalier de l'Université de Montréal (CHUM)
 2011-05 PHASE2
NCT01592279 UNKNOWN
Uncontrolled Type 1 Diabetic Patients
Hadassah Medical Organization
 2012-06 PHASE4
NCT02187250 COMPLETED
PCOS; Obesity
University Medical Centre Ljubljana
 2014-03 PHASE4
NCT01597531 TERMINATED
Type 2 Diabetes; Gastric Banding
East Carolina University
 2012-06 PHASE4
NCT01733758 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2013-02 PHASE3
NCT01562678 COMPLETED
Diabetes; Effects of Liraglutide Administration on Brain Activity; Weight Loss; Hunger
Beth Israel Deaconess Medical Center
 2012-03 PHASE4
NCT01392898 UNKNOWN
Type 2 Diabetes Mellitus
Radboud University Medical Center
 2012-02
NCT01789086 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2013-02 PHASE1
NCT01722266 COMPLETED
Type 1 Diabetes
University at Buffalo
 2012-11-01 PHASE3
NCT01937598 COMPLETED
Type 2 Diabetes
Michael A. Nauck
 2013-08 PHASE3
NCT01676116 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-08-29 PHASE3
NCT01785043 COMPLETED
DIABETES Mellitus Type 2 Not Well Controlled
Anna Cruceta
 2013-03 PHASE4
NCT01664676 COMPLETED
Type 2 Diabetes Mellitus
University of Aarhus
 2012-12 PHASE4
NCT01755572 COMPLETED
Type 2 Diabetes; Systolic Hypertension
Mount Sinai Hospital, Canada
 2013-01 PHASE4
NCT01664247 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-10-01 PHASE3
NCT02104037 COMPLETED
Liraglutide Blood-brain Transfer
Mikkel Christensen
 2012-01
NCT01550653 COMPLETED
Healthy
University of Luebeck
 2012-05 PHASE1
NCT01593137 WITHDRAWN
Type 2 Diabetes
Fundación Fernández-Cruz
 2012-05 PHASE4
NCT01270789 COMPLETED
Type 2 Diabetes
Mount Sinai Hospital, Canada
 2011-01 PHASE3
NCT01654120 COMPLETED
Diabetes Mellitus, Type II
Mountain Diabetes and Endocrine Center
 2011-12 PHASE4
NCT01624259 COMPLETED
Type 2 Diabetes
Eli Lilly and Company
 2012-06 PHASE3
NCT01916174 COMPLETED
Diabetes; Diabetes Mellitus, Type 2; Healthy
Novo Nordisk A/S
 2013-08 PHASE1
NCT01638260 TERMINATED
Type 2 Diabetes Mellitus
Maastricht University Medical Center
 2012-10 PHASE4
NCT01618162 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-08-29 PHASE3
NCT01394341 COMPLETED
Type 2 Diabetes Mellitus; End-stage Renal Disease
Bo Feldt-Rasmussen
 2011-09 PHASE4
NCT01739049 COMPLETED
Binge Eating Behaviour
Universiti Kebangsaan Malaysia Medical Centre
 2012-11 PHASE4
NCT01617434 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-09 PHASE3
NCT01558271 COMPLETED
Type 2 Diabetes Mellitus
Eli Lilly and Company
 2012-03 PHASE3
NCT01725126 COMPLETED
Obesity
GlaxoSmithKline
 2013-02-10 PHASE2
NCT01620489 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-06-14 PHASE3
NCT01610934 COMPLETED
Maturity-onset Diabetes of the Young
University Hospital, Gentofte, Copenhagen
 2012-08 PHASE2; PHASE3
NCT01596504 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2012-05 PHASE2
NCT01499108 COMPLETED
Type 2 Diabetes
Peter Rossing
 2012-08 PHASE4
NCT01206101 TERMINATED
Diabetes; Diabetes Mellitus, Type 1
Novo Nordisk A/S
 2012-03-21 PHASE2
NCT01557166 COMPLETED
Metabolism and Nutrition Disorder; Obesity; Obstructive Sleep Apnoea
Novo Nordisk A/S
 2012-06-07 PHASE3
NCT01455441 COMPLETED
Type 2 Diabetes
Tina Vilsboll
 2011-10 PHASE4
NCT01460069 COMPLETED
Psoriasis
Annesofie Faurschou
 2011-10
NCT01512108 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-01-10 PHASE3
NCT01469351 COMPLETED
Alzheimers Disease
University of Aarhus
 2012-01
NCT01272219 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2011-06-01 PHASE3
NCT01542242 TERMINATED
Diabetes Mellitus Type 2; Prader Willi Syndrome
Vancouver General Hospital
 2012-02 PHASE4
NCT01272232 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2011-06-01 PHASE3
NCT01784965 COMPLETED
Pre-diabetes; Older Adults
Stanford University
 2009-12 PHASE3
NCT02292290 COMPLETED
Type 2 Diabetes
University of Leicester
 2011-04 PHASE4
NCT01451905 UNKNOWN
Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
University Hospital, Gentofte, Copenhagen
 2011-08
NCT01572740 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-04-05 PHASE3
NCT01392573 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2011-11-28 PHASE3
NCT01899430 COMPLETED
PCOS; Obesity
University Medical Centre Ljubljana
 2011-11 PHASE4
NCT01911468 COMPLETED
PCOS; Obesity
University Medical Centre Ljubljana
 2011-11 PHASE4
NCT01117350 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2010-07 PHASE4
NCT01518101 COMPLETED
Type 2 Diabetes
Novartis Pharmaceuticals
 2012-01 PHASE4
NCT01536665 COMPLETED
Diabetes; Diabetes Mellitus, Type 1
Novo Nordisk A/S
 2012-02 PHASE1
NCT01388361 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2011-09 PHASE3
NCT01336023 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2011-05-23 PHASE3
NCT01473953 COMPLETED
Diabetes; Diabetes Mellitus, Type 2; Healthy
Novo Nordisk A/S
 2011-10 PHASE1
NCT01296412 COMPLETED
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC
 2011-03-11 PHASE3
NCT01695109 COMPLETED
Healthy Human Male Subjects
Medical University of Vienna
 2010-11 PHASE4
NCT01516476 TERMINATED
Diabetes Mellitus Type 2
Hoffmann-La Roche
 2011-11 PHASE2
NCT00943501 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-11 PHASE1
NCT01128894 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2010-05 PHASE3
NCT01373450 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2011-06 PHASE1
NCT00978393 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2009-09-16 PHASE1
NCT01319240 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2011-03 PHASE1
NCT01029886 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2010-01 PHASE3
NCT01599338 COMPLETED
Type 2 Diabetes Mellitus; Overweight
Centre Hospitalier Universitaire Dijon
 2011-01
NCT00993304 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-10 PHASE1
NCT01175473 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2010-08 PHASE2
NCT01208012 COMPLETED
Diabetes Mellitus, Type 2
ikfe-CRO GmbH
 2010-04 PHASE4
NCT00993720 COMPLETED
Diabetes Mellitus
Hvidovre University Hospital
 2009-10 PHASE2; PHASE3
NCT00781937 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2008-10-30 PHASE3
NCT00620282 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-02 PHASE3
NCT00856986 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-03 PHASE3
NCT00983021 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2009-09 PHASE1
NCT00873223 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-03 PHASE1
NCT00700817 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-06 PHASE3
NCT00696657 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-06-03 PHASE2
NCT00614120 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-01 PHASE3
NCT00761540 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2008-10 PHASE1
NCT00294723 TERMINATED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-02 PHASE3
NCT00518882 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2007-08 PHASE3
NCT00393718 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-11 PHASE3
NCT00395746 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-10 PHASE3
NCT00422058 COMPLETED
Metabolism and Nutrition Disorder; Obesity
Novo Nordisk A/S
 2007-01-10 PHASE2
NCT01511692 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2005-11 PHASE1
NCT00333151 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-05 PHASE3
NCT01513525 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2007-02 PHASE1
NCT01517555 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-10 PHASE1
NCT00318461 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-05 PHASE3
NCT00318422 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-05 PHASE3
NCT01515553 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2007-01 PHASE1
NCT01508858 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-11 PHASE1
NCT01518166 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2006-05 PHASE1
NCT00331851 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-05 PHASE3
NCT01517568 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2006-11 PHASE1
NCT01516255 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-07 PHASE1
NCT01507389 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-03 PHASE1
NCT01515579 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2006-04 PHASE1
NCT00154414 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2005-01 PHASE2
NCT01515592 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-01 PHASE1
NCT01508806 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2005-08 PHASE1
NCT00154401 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2005-01 PHASE2
NCT01514487 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2005-01-13 PHASE1
NCT01508897 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2004-05-28 PHASE1
NCT01507337 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2004-04 PHASE1
NCT01620476 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2003-09 PHASE1
NCT01615978 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2003-12 PHASE1
NCT01620463 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2002-12 PHASE1
NCT01511172 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2002-08 PHASE2
NCT01508949 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2001-06 PHASE2
NCT01508923 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2001-05 PHASE2
NCT01511159 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2001-10 PHASE1
NCT01509742 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2001-04 PHASE1
NCT01511198 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2001-02 PHASE2
NCT01509755 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2000-10 PHASE2
NCT01511185 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2001-02 PHASE1
NCT01507311 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 1999-09 PHASE1
NCT01507272 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 1999-03 PHASE1
NCT01507285 COMPLETED
Diabetes; Diabetes Mellitus, Type 2; Healthy
Novo Nordisk A/S
 1999-08 PHASE1

(data from https://clinicaltrials.gov, updated on 2025-05-29)

Check the Liraglutide product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

Liraglutide selectively binds to and activates the glucagon-like peptide-1 receptor, which stimulates glucose-dependent insulin secretion and suppresses postprandial glucagon release from pancreatic islet cells. This signaling cascade improves glycemic regulation and promotes satiety through delayed gastric emptying, directly mediating its therapeutic efficacy in clinical trial conditions such as type 2 diabetes mellitus and obesity.

Appendix RUO and cGMP Quality Standards

Quality Dimension RUO (Research Use Only) cGMP (Current Good Manufacturing Practice)
Clinical Applicability Prohibited in human clinical trials or medical diagnostics. Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status Non-regulated grade; exempt from drug manufacturing laws. Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment Unclassified analytical or research laboratories. Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control Basic purity and activity testing. Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation Basic equipment calibration; no process validation required. Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance Vendor self-declared without required formal QMS. Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact High risk of IND rejection if used as a critical raw material. Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).

Jump to

Note: Technical data last updated: Sep 1, 2026.